At about 33.5 million children, the world's largest ever measles immunization program is due to get under way in Bangladesh on February 25, for the following three weeks. The aim is to provide countrywide coverage for the southern Asian country's population of under 10 year old children. According to the World Health Organization, 20,000 Bangladeshi children die annually from measles.
The United Nations Children's Fund (UNICEF) is co-sponsoring the campaign along with the Bangladesh government, the WHO and other partners. A UNICEF spokesman told the Marketletter that the Measles Start Up campaign was made possible because the organization had secured two-to four-year production forecasts from manufacturers.
"...there is still a very tense situation"
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze